π§ Acoustic neuroma (vestibular schwannoma) is a benign tumour of Schwann cells affecting cranial nerve VIII.
π Accounts for ~8% of primary intracranial tumours and is the most common mass in the cerebellopontine angle.
π‘ Always suspect in patients with unilateral sensorineural hearing loss (USNHL) until proven otherwise.
π About
- Benign schwannoma of the vestibulocochlear nerve (CN VIII).
- ~8% of intracranial tumours; ~80% of CPA lesions.
- Associated with NF2 β bilateral tumours (merlin gene mutation).
- Slow-growing but cause morbidity through local compression.
𧬠Aetiology
- Schwann cell proliferation (myelinating cells of peripheral nerves).
- Sporadic (majority) or inherited (NF2, autosomal dominant).
- Rare link with prior childhood cranial irradiation.
β οΈ Risk Factors
- Age 40β60 years.
- NF2 or strong family history.
- High-dose cranial irradiation in childhood.
π Effects of Tumour Expansion
- CN VIII β unilateral SNHL, tinnitus, imbalance π§.
- CN V β facial numbness, loss of corneal reflex.
- CN VII β LMN facial palsy, taste disturbance.
- Cerebellum β ipsilateral ataxia, unsteady gait πΆ.
- Brainstem β compression, hydrocephalus, raised ICP.
- Raised ICP β headache, nausea, papilloedema.
π©Ί Clinical Features
- Unilateral SNHL (~95%).
- Tinnitus (buzzing/ringing).
- Vertigo, imbalance, disequilibrium.
- Facial numbness, paraesthesia.
- Facial weakness (late feature).
- Headache, vomiting (raised ICP).
- Ataxia, poor coordination.
- Think NF2 if bilateral lesions.
π‘ Exam Pearl: Any patient with USNHL Β± unilateral tinnitus β arrange MRI internal auditory meatus (IAM) to exclude vestibular schwannoma.
π Investigations
- Pure tone audiometry β confirms SNHL.
- MRI IAM with gadolinium (gold standard) β βice-cream coneβ lesion π¦.
- CT if MRI contraindicated β bone erosion, large lesions.
- BAEP (brainstem auditory evoked potentials) β pathway integrity.
- CSF protein β (nonspecific).
- Genetic testing if NF2 suspected.
π§Ύ Differential Diagnosis
- Cerebellopontine angle meningioma.
- Epidermoid cyst.
- Other schwannomas (rare).
- Metastases.
- Multiple sclerosis (SNHL mimic).
π οΈ Management
- π Observation: small, incidental lesions; elderly/frail patients β serial MRI.
- πͺ Microsurgery: translabyrinthine, retrosigmoid, or middle fossa approach depending on tumour size/location.
- π― Stereotactic radiosurgery (Gamma Knife / CyberKnife): for small-medium tumours or poor surgical candidates.
- π‘ Fractionated radiotherapy: selected cases.
- π§ Rehabilitation: hearing aids, vestibular rehab, facial nerve physiotherapy.
- MDT: neurosurgery, ENT, audiology, neuroradiology, genetics (NF2).
π Prognosis
- Good outcome if detected early.
- Hearing preservation depends on tumour size and surgical approach.
- Recurrence risk ~5% β long-term follow-up essential.
- Untreated β progressive compression, hydrocephalus, death.
π Prevention & Screening
- No prevention for sporadic cases.
- NF2 β genetic counselling, baseline + interval MRI scans.
π References